CN110354351B - Medicine generator and health data management platform - Google Patents

Medicine generator and health data management platform Download PDF

Info

Publication number
CN110354351B
CN110354351B CN201910652532.6A CN201910652532A CN110354351B CN 110354351 B CN110354351 B CN 110354351B CN 201910652532 A CN201910652532 A CN 201910652532A CN 110354351 B CN110354351 B CN 110354351B
Authority
CN
China
Prior art keywords
generator
atomizing
base
atomizing core
mobile terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910652532.6A
Other languages
Chinese (zh)
Other versions
CN110354351A (en
Inventor
盛林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Xiangyue Technology Co.,Ltd.
Original Assignee
Beijing Xiangyue Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Xiangyue Technology Co ltd filed Critical Beijing Xiangyue Technology Co ltd
Priority to CN201910652532.6A priority Critical patent/CN110354351B/en
Publication of CN110354351A publication Critical patent/CN110354351A/en
Application granted granted Critical
Publication of CN110354351B publication Critical patent/CN110354351B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical

Abstract

The invention relates to a medicine generator and a health data management platform, and belongs to the field of health tools. The utility model provides a medicine generator, includes housing assembly, suction nozzle, base, the atomizing core of making by the medicine, the atomizing solvent and the center tube of making by the medicine, base, center tube and suction nozzle form and hold the cavity structure of atomizing core, the atomizing solvent fills the setting and is in the cavity structure, the atomizing core is fixed to be set up on the base, the base with housing assembly can dismantle the connection, the inboard parcel of atomizing core is provided with the heater strip, the heater strip with the housing assembly electricity is connected, the suction nozzle with the connection can be dismantled to the center tube, atomizing core boiling point is greater than atomizing solvent's boiling point. Solves the problem of low absorption rate of the traditional administration route.

Description

Medicine generator and health data management platform
Technical Field
The invention relates to the field of health care tools, in particular to a medicine generator and a health data management platform.
Background
In the traditional oral administration mode, the main absorption part is small intestine, and the absorption mode is fat-soluble diffusion, so that most of medicines are metabolized and inactivated when passing through gastrointestinal tracts, intestinal mucosa and liver, the dosage entering systemic circulation is reduced, and the absorption rate of the traditional administration route is low. For example, epigallocatechin gallate (abbreviated as EGCG) has strong hydrogen donating capability due to its phenolic hydroxyl group, is easily oxidized to generate o-quinones and biphenol-quinones, is easily degraded by body fluid, and has poor stability, resulting in short retention time, low absorption rate and low bioavailability of EGCG in intestines and stomach of human body. However, in vivo and in vitro experiments prove that EGCG can effectively prevent and treat various diseases, such as free radical DNA damage resistance, radiation and ultraviolet ray resistance, lipid peroxidation prevention, serum low-density cholesterol, ultralow-density cholesterol and triglyceride content reduction, interference of signal transmission required by cancer cell survival, inhibition of carcinogens in diet, prevention of activity of certain carcinogens under the action of other enzymes and antioxidants in intestines, livers and lungs, free radical scavenging, pollution resistance, solarization resistance and smoking resistance, and prevention and treatment of skin aging and wrinkling. Therefore, the low absorption rate of the traditional administration route greatly limits the EGCG in the treatment and prevention fields of depression, tumor resistance, weight reduction, aging resistance, senile dementia resistance and the like.
At present, the following problems exist for the traditional mode of taking medicines: 1. the traditional administration route has low absorption rate; 2. early screening and instant intervention of patients cannot be realized, so that the development of the disease course is controlled; 3. the intervention execution condition and effect cannot be monitored, so that the intervention scheme cannot be effectively adjusted in time.
Disclosure of Invention
The invention aims to provide a drug generator and a health data management platform, and solves the problem of low absorption rate of the traditional administration route.
The technical scheme for solving the technical problems is as follows: the utility model provides a medicine generator, includes housing assembly, suction nozzle, base, the atomizing core of making by the medicine, the atomizing solvent and the center tube of making by the medicine, base, center tube and suction nozzle form and hold the cavity structure of atomizing core, the atomizing solvent fills the setting and is in the cavity structure, the atomizing core is fixed to be set up on the base, the base with housing assembly can dismantle the connection, the inboard parcel of atomizing core is provided with the heater strip, the heater strip with the housing assembly electricity is connected, the suction nozzle with the connection can be dismantled to the center tube, atomizing core boiling point is greater than atomizing solvent's boiling point.
Further, casing assembly includes casing body and sets up at inside battery pack, intelligent memory chip, bluetooth part, spatial position sensor, the control switch of casing body, intelligent memory chip with the control switch all with the battery pack electricity is connected, bluetooth part, spatial position sensor all with intelligent memory chip electricity signal connection, casing body with the connection can be dismantled to the base, the control switch with the heater strip electricity is connected.
Further, still include supersonic generator, supersonic generator sets up the atomizing core with between the base, supersonic generator with base fixed connection, supersonic generator with the control switch electricity is connected.
Further, the atomization core is made of epigallocatechin gallate, and the atomization solvent is cannabidiol.
Further, the shell assembly further comprises a prompt component, the prompt component is connected with the intelligent storage chip, and the prompt component is a vibration generator, a light generator or a sound generator.
A health data management platform comprises a user mobile terminal and a medicine generator, wherein the user mobile terminal is in signal connection with the medicine generator.
The system further comprises a cloud end, wherein the cloud end is used for a computer and storing data generated by the user mobile terminal.
Further, the cloud terminal comprises a doctor mobile terminal, and the doctor mobile terminal is used for displaying or downloading the data stored in the cloud terminal.
The invention provides a medicine generator which comprises a shell component, a suction nozzle, a base, an atomizing core made of medicines, an atomizing solvent made of medicines and a central tube, wherein the base, the central tube and the suction nozzle form a cavity structure for accommodating the atomizing core, the atomizing solvent is filled in the cavity structure, the atomizing core is fixedly arranged on the base, the base is detachably connected with the shell component, a heating wire is wrapped on the inner side of the atomizing core, the heating wire is electrically connected with the shell component, the suction nozzle is detachably connected with the central tube, and the boiling point of the atomizing core is larger than that of the atomizing solvent. Therefore, the shell component provides electric energy for the heating wire, the heating wire provides heat energy for the atomizing core when in work, the atomizing core made of the epigallocatechin gallate is firstly melted and then atomized into tiny particles under the action of the heating wire, and the medicine particles enter the respiratory tract and the lung in a respiratory inhalation mode, so that the absorptivity of the epigallocatechin gallate is greatly improved, and the purpose of quick and effective treatment is achieved.
The invention provides a health data management platform which comprises a user mobile terminal and a medicine generator, wherein the user mobile terminal is in signal connection with the medicine generator. Thus, when the drug generator is used by a patient, the drug generator can also atomize epigallocatechin gallate and increase the absorption rate of the epigallocatechin gallate through the form of pulmonary inhalation. In addition, the spatial position sensor can record the absorption frequency and the dosage in the lung of a patient, the recorded data is stored in the intelligent storage chip, the mobile terminal of the user extracts and observes the behavior data of the patient, and the data model is used for analyzing so as to realize early screening and intervention on the patient.
Drawings
FIG. 1 is a cross-sectional view of a drug generator according to the present invention;
FIG. 2 is a schematic diagram of the electrical connections within the drug generator of the present invention;
FIG. 3 is a diagram of the architecture of the health data management platform of the present invention;
FIG. 4 is a technical architecture diagram of another embodiment of the health data management platform of the present invention.
In the drawings, the components represented by the respective reference numerals are listed below:
1. the device comprises a shell assembly, 2, a suction nozzle, 3, a base, 4, an atomization core, 5, a central pipe, 6, a heating wire, 7, a shell body, 8, a battery assembly, 9, an intelligent storage chip, 10, a Bluetooth component, 11, a spatial position sensor, 12, a control switch, 13, an ultrasonic generator, 14, a prompt component, 15, a user mobile terminal, 16, a cloud, 17 and a doctor mobile terminal.
Detailed Description
The principles and features of this invention are described below in conjunction with the following drawings, which are set forth by way of illustration only and are not intended to limit the scope of the invention.
In the description of the present invention, it is to be understood that the terms "upper", "lower", "center", "inner", "outer", "top", "bottom", and the like, indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, and are only for convenience in describing the present invention and simplifying the description, but do not indicate or imply that the device or element referred to must have a particular orientation, be constructed and operated in a particular orientation, and thus, should not be construed as limiting the present invention.
In the description of the present invention, it should be noted that, unless otherwise explicitly specified or limited, the terms "mounted," "connected," and "connected" are to be construed broadly, e.g., as meaning either a fixed connection, a removable connection, or an integral connection; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meanings of the above terms in the present invention can be understood in specific cases to those skilled in the art.
As shown in fig. 1-2, the present invention provides a drug generator, which includes a housing assembly 1, a suction nozzle 2, a base 3, an atomizing core 4 made of a drug, an atomizing solvent made of a drug, and a central tube 5, wherein the base 3, the central tube 5, and the suction nozzle 2 form a cavity structure for accommodating the atomizing core 4, the atomizing solvent is filled in the cavity structure, the atomizing core 4 is fixedly disposed on the base 3, the base 3 is detachably connected to the housing assembly 1, a heating wire 6 is wrapped inside the atomizing core 4, the heating wire 6 is electrically connected to the housing assembly 1, the suction nozzle 2 is detachably connected to the central tube 5, and a boiling point of the atomizing core 4 is greater than a boiling point of the atomizing solvent. Thus, the shell component 1 provides electric energy for the heating wire 6, the heating wire 6 provides heat energy for the atomizing core 4 when working, the atomizing core 4 made of EGCG (Epigallocatechin gallate; English name: Epigallocatechin gate) melts firstly and then is atomized into tiny particles under the action of the heating wire 6, and the drug particles enter respiratory tract and lung by breathing inhalation, thereby greatly improving the absorption rate of EGCG and achieving the purpose of quick and effective treatment.
The drug generator of the present invention, as shown in fig. 1-2, may also be based on the above-described technical solutions: casing assembly 1 includes casing body 7 and sets up at inside battery pack 8, intelligent memory chip 9, bluetooth part 10, spatial position sensor 11, control switch 12 of casing body 7, intelligent memory chip 9 with control switch 12 all with battery pack 8 electricity is connected, bluetooth part 10, spatial position sensor 11 all with intelligent memory chip 9 electricity signal connection, casing body 7 with the connection can be dismantled to base 3, control switch 12 with heater strip 6 electricity is connected. Like this, the inside battery pack 8 of casing body 7 provides the electric energy for intelligent memory chip 9 and control switch 12, battery pack 8 is the bluetooth through intelligent memory chip 9, spatial position sensor 11 indirectly provides the electric energy, battery pack 8 provides the electric energy for heater strip 6 indirectly through control switch 12 again, spatial position sensor 11 can take notes patient's action data and the interior intake frequency and the dose of dosing of lung when patient uses medicine generator, and the data storage who will take notes in intelligent memory chip 9, and then through bluetooth part 10 with the action data transmission to terminal that above-mentioned medicine generator gathered, extract through the terminal, observe patient's action data intelligence and judge patient's sick risk and provide technical intervention scheme, the monitoring intervenes the execution and carries out periodic evaluation.
The points to be explained here are: the control switch 12 may be a dip switch, a cam switch, a dial switch, a toggle switch, a tact switch, or a ship-type switch, and the form of the control switch 12 is known in the art and will not be described herein.
The drug generator of the present invention, as shown in fig. 1-2, may also be based on the above-described technical solutions: still include supersonic generator 13, supersonic generator 13 sets up atomizing core 4 with between the base 3, supersonic generator 13 with base 3 fixed connection, supersonic generator 13 with control switch 12 electricity is connected. Thus, the battery pack 8 indirectly provides electric energy for the ultrasonic generator 13 through the control switch 12, after the control switch 12 is triggered, the ultrasonic generator 13 converts the electric energy into ultrasonic energy, the ultrasonic energy atomizes the gaseous and molten medicines into 1um to 5um micro fog particles under the action of the heating wire, and sprays the liquid medicine into fog under the action of ultrasonic directional pressure, so that the liquid medicine is inhaled by the lung of a patient, and the EGCG absorption rate is improved.
The drug generator of the present invention, as shown in fig. 1-2, may also be based on the above-described technical solutions: the atomization core (4) is made of epigallocatechin gallate, and the atomization solvent is cannabidiol. Cannabidiol is a main chemical component in medicinal plant cannabis sativa, is extracted from female cannabis sativa plants, is a non-addictive component in cannabis sativa, has pharmacological effects of resisting spasm, resisting anxiety, resisting inflammation and the like, can be used for treating various difficult and complicated diseases, can effectively eliminate hallucinogenic effect of Tetrahydrocannabinol (THC) on human bodies, is called as an 'antitoxic compound', is an important substance for helping depression patients to reduce anxiety mood, exists in human bodies, and can help endogenous cannabinoids to be maintained at a reasonable level, so that the patients feel good and pleasant without being addicted like THC. Thus, the melting point of the atomization solvent CBD (Chinese name: Cannabidiol; English name: (-) -Cannabidiaol) is about 60 ℃, the boiling point is about 280 ℃, the melting point of EGCG is about 260 ℃, the boiling point is above 900 ℃, when the heating temperature of the heating wire of the atomization solvent CBD reaches above 280 ℃, the ultrasonic generator 13 atomizes the gaseous CBD into micro-particles, under the temperature, EGCG can be quantitatively dissolved in a CBD atomization solvent, CBD tiny particles can be sprayed into mist together with liquid EGCG under the action of ultrasonic directional pressure, thereby realizing the mixing of EGCG and CBD under the atomizing state, further being inhaled by patients, improving the absorptivity of EGCG, and the combination of EGCG and CBD with antidepressant and epilepsy has better drug efficacy, wherein, the mixed preparation of the EGCG and the CBD can realize the mixing of 5 percent to 95 percent with different proportions by adjusting the atomization degree.
The drug generator of the present invention, as shown in fig. 1-2, may also be based on the above-described technical solutions: the shell assembly 1 further comprises a prompting component 14, the prompting component 14 is connected with the intelligent storage chip 9, and the prompting component 14 is a vibration generator, a light generator or a sound generator. In this way, the prompting component 14 prompts the patient to take the medicine according to the personalized medicine administration scheme, and the patient symptoms are intelligently improved. The vibration transmitter may be arranged inside the drug generator housing assembly 1; the light generator is typically located at the bottom or side of the housing assembly 1; to ensure aesthetics, convenience and practicality, the sound generator is typically disposed inside the drug generator housing assembly 1.
As shown in fig. 3 to 4, the present invention provides a health data management platform, which comprises a user mobile terminal 15 and a medicine generator, wherein the user mobile terminal 15 is in signal connection with the medicine generator. Thus, when the patient uses the drug generator, the spatial position sensor 11 records the behavior data of the patient and the inhalation frequency and the dosage of the intrapulmonary administration, the recorded data are stored in the intelligent storage chip 9, the user mobile terminal 15 analyzes by extracting and observing the behavior data of the patient through an established data model so as to realize early screening and intervention on the patient, the doctor mobile terminal 17 provides case management, follow-up visit management and electronic health record management for the patient according to the data calculated and evaluated by the cloud terminal 16, and simultaneously monitors the execution condition and effect of the intervention so as to realize intelligent regulation of the administration scheme.
As shown in fig. 3 to 4, the health data management platform of the present invention may further include, on the basis of the foregoing technical solutions: a cloud 16 is also included, the cloud 16 being used for computing and storing data generated by the user mobile terminal 15. Thus, without a communication network connection, the cloud 16 can directly calculate and store the data collected by the drug generator, and can also realize patient data sharing.
As shown in fig. 3 to 4, the health data management platform of the present invention may further include, on the basis of the foregoing technical solutions: the system further comprises a doctor mobile terminal 17, and the doctor mobile terminal 17 is used for displaying or downloading data stored in the cloud 16. Therefore, the user mobile terminal 15, the doctor mobile terminal 17 and the cloud 16 jointly constitute a doctor-patient platform, a doctor can perform real-time consultation and time-sharing consultation on a patient through the doctor-patient platform to form a comprehensive consultation platform, and the doctor mobile terminal 17 can also provide remote doctor case management, follow-up visit management and electronic health file management for the patient according to data acquired by the cloud 16 to form a light-visit platform. The user mobile terminal 15 and the doctor mobile terminal 17 can download and view the patient data stored in the cloud terminal 16 at any time, and then adjust the treatment scheme of the patient in time.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (6)

1. A medication generator, comprising: the atomizing device comprises a shell component (1), a suction nozzle (2), a base (3), an atomizing core (4) made of medicine, an atomizing solvent made of medicine and a central tube (5), wherein the base (3), the central tube (5) and the suction nozzle (2) form a cavity structure for accommodating the atomizing core (4), the atomizing solvent is filled in the cavity structure, the atomizing core (4) is fixedly arranged on the base (3), the base (3) is detachably connected with the shell component (1), a heating wire (6) is wrapped on the inner side of the atomizing core (4), the heating wire (6) is electrically connected with the shell component (1), the suction nozzle (2) is detachably connected with the central tube (5), and the boiling point of the atomizing core (4) is greater than that of the atomizing solvent;
the atomizing device is characterized by further comprising an ultrasonic generator (13), wherein the ultrasonic generator (13) is arranged between the atomizing core (4) and the base (3), the ultrasonic generator (13) is fixedly connected with the base (3), and the ultrasonic generator (13) is electrically connected with the control switch (12);
the atomization core (4) is made of epigallocatechin gallate, and the atomization solvent is cannabidiol.
2. The drug generator of claim 1, wherein: casing subassembly (1) includes casing body (7) and sets up at inside battery pack (8), intelligent memory chip (9), bluetooth part (10), spatial position sensor (11), control switch (12) of casing body (7), intelligent memory chip (9) with control switch (12) all with battery pack (8) electricity is connected, bluetooth part (10), spatial position sensor (11) all with intelligent memory chip (9) signal of telecommunication connects, casing body (7) with base (3) can dismantle the connection, control switch (12) with heater strip (6) electricity is connected.
3. The drug generator of any of claims 1-2, wherein: the shell assembly (1) further comprises a prompt component (14), the prompt component (14) is connected with the intelligent storage chip (9), and the prompt component (14) is a vibration generator, a light generator or a sound generator.
4. A health data management platform, comprising: comprising a user mobile terminal (15) and a medication generator according to any of claims 1-3, said user mobile terminal (15) being in signal connection with said medication generator.
5. The health data management platform of claim 4, wherein: the system also comprises a cloud end (16), wherein the cloud end (16) is used for calculating and storing data generated by the user mobile terminal (15).
6. The health data management platform of claim 5, wherein: the system further comprises a doctor mobile terminal (17), wherein the doctor mobile terminal (17) is used for displaying or downloading data stored in the cloud end (16).
CN201910652532.6A 2019-07-19 2019-07-19 Medicine generator and health data management platform Active CN110354351B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910652532.6A CN110354351B (en) 2019-07-19 2019-07-19 Medicine generator and health data management platform

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910652532.6A CN110354351B (en) 2019-07-19 2019-07-19 Medicine generator and health data management platform

Publications (2)

Publication Number Publication Date
CN110354351A CN110354351A (en) 2019-10-22
CN110354351B true CN110354351B (en) 2022-03-22

Family

ID=68220306

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910652532.6A Active CN110354351B (en) 2019-07-19 2019-07-19 Medicine generator and health data management platform

Country Status (1)

Country Link
CN (1) CN110354351B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113384781B (en) * 2020-03-11 2024-03-29 李彤 EGCG atomizing system
CN115778941A (en) * 2022-11-18 2023-03-14 哈尔滨医科大学 Anti-neocoronavirus combined pharmaceutical composition and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN204653790U (en) * 2015-05-22 2015-09-23 陕西中烟工业有限责任公司 A kind of solid-liquid atomization core of integral type
CN204840552U (en) * 2015-08-04 2015-12-09 上海朔茂网络科技有限公司 Atomizer atomizing information monitoring devices
CN105188426A (en) * 2013-02-22 2015-12-23 奥驰亚客户服务公司 Electronic smoking article
CN105555157A (en) * 2013-07-24 2016-05-04 Sis资源有限公司 Solid core electronic cigarette
CN109152426A (en) * 2016-05-31 2019-01-04 菲利普莫里斯生产公司 The heated type aerosol for forming matrix and flammable heater element with liquid aersol generates product

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9877509B2 (en) * 2014-03-31 2018-01-30 Westfield Limited (Ltd.) Micro-vaporizer heating element and method of vaporization

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188426A (en) * 2013-02-22 2015-12-23 奥驰亚客户服务公司 Electronic smoking article
CN105555157A (en) * 2013-07-24 2016-05-04 Sis资源有限公司 Solid core electronic cigarette
CN204653790U (en) * 2015-05-22 2015-09-23 陕西中烟工业有限责任公司 A kind of solid-liquid atomization core of integral type
CN204840552U (en) * 2015-08-04 2015-12-09 上海朔茂网络科技有限公司 Atomizer atomizing information monitoring devices
CN109152426A (en) * 2016-05-31 2019-01-04 菲利普莫里斯生产公司 The heated type aerosol for forming matrix and flammable heater element with liquid aersol generates product

Also Published As

Publication number Publication date
CN110354351A (en) 2019-10-22

Similar Documents

Publication Publication Date Title
CN110354351B (en) Medicine generator and health data management platform
CN111214736A (en) Intelligent micro-grid atomizer and atomization system
JP2020510499A (en) Mobile production system and method for nitric oxide
CN212308592U (en) Intelligent micro-grid atomizer and atomization system
AU3637500A (en) Liquid composition to be vaporized for inhibiting increase in blood sugar level, vaporizer for the same and use of the same
CN105031783B (en) A kind of wearable intelligent nebulization equipment
CN108355212A (en) A kind of atomizing inhalation device for paediatric internal medicine
CN109498950A (en) A kind of pediatric medicine breathing intelligent breathing device
CN110116416B (en) Elderly companion drug administration health care robot and drug administration method thereof
CN206805541U (en) A kind of respiratory disorder intelligence diagnosis and treatment integral system
CN210785891U (en) Insomnia therapeutic instrument
CN107213538A (en) The drug storage of nebulizer administration and atomising device
EP3537972B1 (en) System for treating tinnitus
CN205041925U (en) Wearable intelligence aerosol inhalation device
CN208582819U (en) Nebulizer
CN210145231U (en) Intelligent atomizer
CN108853661A (en) A kind of interactive system of compression atomizer operational data
CN208799630U (en) A kind of paediatrics flu rehabilitation atomising device
CN219271823U (en) Hydrogen and traditional Chinese medicine co-inhalation atomization system and atomizer
WO2020029469A1 (en) Icu-special portable atomizing device enabling autonomously breathing according to airflow
CN206197134U (en) A kind of electronic gauze mask for tackling haze weather
CN200987819Y (en) Oxygen mask with atomization function
CN216877475U (en) Portable medical atomizer
CN215024214U (en) Integral atomizing medicine feeder
CN105126213B (en) Portable first-aid inhalation system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20220120

Address after: 100071 1-3, floor 1, building 1, Zhengyang Beili, Fengtai District, Beijing

Applicant after: Beijing Xiangyue Technology Co.,Ltd.

Address before: 100000 room 304, building 1, middle building zone 1, No. 50, xingshikou Road, Haidian District, Beijing

Applicant before: Zhejiang Yukangqing Biomedical Co.,Ltd.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant